SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM / Interim Management Statement

22 Apr 2015 07:00

ELEMENTIS PLC - AGM / Interim Management Statement

ELEMENTIS PLC - AGM / Interim Management Statement

PR Newswire

London, April 21

22 April 2015 Elementis plc - AGM / Interim Management Statement Elementis plc (ELM.L, the "Company" or the "Group"), the Global SpecialtyChemicals Company, today issues its Interim Management Statement for the threemonths ended 31 March 2015. Commenting on the Company's performance Group Chief Executive, David Dutro,said: "Despite subdued global economic activity,the Elementis team hasdelivered encouraging results in the first quarter of 2015 and we remainconfident in the Group's prospects for the coming year. Moving forward ourstrategy is clear and focused on delivering long-term shareholder value. Weremain resolute in our commitment to outperform our competitors by providinginnovative products and solutions that make our customers more successful. Wehave continued to invest in the future growth of our Specialty Productsbusiness andalthough we are currently in the phase of absorbing the additionalrelated costs,these investmentsare the building blocks of an exciting future". CurrencyConsistent with the Group's Final Results statement in February this year,currency movements reduced Group sales for the first quarter by 5 per centcompared to the same period last year, however, operating profit was impactedby less than 1 per cent, assisted by the Group's hedging programme. In order toprovide a clearer understanding of the Group's underlying performance thefollowing business commentaries focus on constant currency sales ("CC sales"). In Specialty Products, CC sales in the first quarter were 3 per cent higherthan the same period last year and operating margins improved by 50 basispoints, assisted by currency movements. * In coatings additives, CC sales in North America were 4 per cent higher than the previous year, with good growth in decorative coatings as a result of new innovative products from the recently commissioned facility in New Martinsville. Sales in Latin America were 9 per cent higher as the business continued to successfully expand sales outside of Brazil. Sales in Asia Pacific were 5 per cent higher, benefiting from ongoing market share gains in China and good progress in other countries. In Europe, despite relatively subdued economic activity, sales grew by 5 per cent due to new product launches in decorative applications and market share gains. * In personal care, CC sales were 6 per cent higher than the same period last year with good growth in North America, Asia Pacific and Latin America. The business team continues to successfully expand the business both geographically and through new product introductions. * As anticipated, CC sales in oilfield were 13 per cent lower than the first quarter of 2014, as lower oil prices impacted on drilling activity across most of the customer base. In Chromium, there was no significant currency translation impact on sales andoperating profit. Sales volumes in the first quarter were 7 per cent lower thanthe same period last year as demand for refractory grade chrome oxide, whichwas particularly strong in 2014, returned to more normal levels following thecompletion of a number of significant customer projects. Otherwise sales inleather tanning and timber treatment continued to show good growth. Fixed costsin the period benefited from plant optimisation activities and the positiveresolution of some legacy issues. While markets outside of North Americacontinue to be challenging, management expects a full year result that is inline with the business's stated strategy of "stable earnings and cash flow". The Group's balance sheet remains strong and is expected to be in a net cashposition at the end of the year which, under our current special dividendpolicy, will continue to provide shareholders with attractive returns. ENDS Enquiries: Elementis + 44 (0) 207 408 9300David Dutro, Chief ExecutiveBrian Taylorson, Finance Director FTI Consulting + 44 (0) 203 727 1000Deborah ScottMatthew Cole
Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.